EVALUATION OF NEW DRUGS FOR TREATMENT OF PROSTATE CANCER PATIENTS USING GENE SIGNATURES AND THE CONNECTIVITY MAP DATABASE
$-383,210FY2011Department of DefenseDOD
Beth Israel Deaconess Medical Center, Inc.
Investigators
View source on USAspending →EVALUATION OF NEW DRUGS FOR TREATMENT OF PROSTATE CANCER PATIENTS USING GENE SIGNATURES AND THE CONNECTIVITY MAP DATABASE · GrantIndex